Beiträge zur Kenntniss der Antitoxinbildung

C. Bruck

DOI: https://doi.org/10.1007/BF02284536

1904-12-01

Zeitschrift für Medizinische Mikrobiologie und Immunologie

Abstract:

What problem does this paper attempt to address?

Mesenchymal stem cell-based treatment for cartilage defects in osteoarthritis

Yiying Qi,Gang Feng,Weiqi Yan

DOI: https://doi.org/10.1007/s11033-011-1376-z

IF: 2.7422

2011-01-01

Molecular Biology Reports

Abstract:Osteoarthritis (OA) is a common disorder and the restoration of the diseased articular cartilage in patients with OA is still a challenge for researchers and clinicians. Currently, a variety of experimental strategies have investigated whether mesenchymal stem cells (MSCs) instead of chondrocytes can be used for the regeneration and maintenance of articular cartilage in OA. MSCs can modulate the immune response of individuals and positively influence the microenvironment of the stem cells already present in the diseased tissue. Through direct cell–cell interaction or the secretion of various factors, MSCs can initiate endogenous regenerative activities in the OA joint. Targeted gene-modified MSC-based therapy might further enhance the cartilage regeneration in OA. Conventionally, delivery of MSCs was attained by graft of engineered constructs derived from cell-seeded scaffolds. However, intra-articular MSCs transplantation without scaffolds is a more attractive option for OA treatment. This article briefly summarizes the current knowledge about MSC-based therapy for prevention or treatment of OA, discussing the direct intra-articular injection of MSCs for the treatment of OA in animal models and in clinical applications, as well as potential future strategies for OA treatment.
FLUORESCENCE EXCITATION OF ULTRA-SOFT X-RAY EMISSION SPECTRA USING SYNCHROTRON RADIATION.

K. Feser,J. Muller,G. Wiech,A. Faessler

DOI: https://doi.org/10.1051/JPHYSCOL:1971460

1971-10-01

Abstract:Attemps have been made to use the synchrotron radiation of the 7.5 GeV electron synchrotron DESY for the fluorescence excitation of ultra-soft X-ray emission spectra. The very intense background produced by the scattered radiation of short wavelengths could be reduced so that it was possible to observe the K emission bands of carbon (45 A), boron (67 A) and beryllium (114 A). The results are compared with data obtained by electron excitation. Introduction. In studies of ultra-soft X-ray emission spectra one is compelled so far to use primary excitation for reasons of intensity, if high resolution is required. However, many substances cannot be investigated with this kind of excitation, because they decompose under the influence of the electron bombardment. Distortions by chemical conversion must be expected particularly in the region of ultrasoft X-rays, since only a very thin surface layer of the substance contributes to the intensity of the emitted radiation. Fluorescence excitation of ultra-soft X-ray emission spectra should be possible with the synchrotron radiation which has higher intensity between 20 and 200 than any other known continuous radiation. In the following we report on attempts to excite ultra-soft X-ray emission bands using the synchrotron radiation of the Deutsches Elektronen-Synchrotron DESY, Hamburg. Experimental arrangement. The measurements were performed using a 2 m grazing incidence concave grating spectrometer [I] with photoelectric registration. Blazed gratings with 1200 and 2 400 lineslmm were used. The resolution was 0.15 A. The detector is a continuous dynode electron multiplier with thin layers of carbon as dynodes [2]. The spectra were recorded by scanning in steps. Because of the fluctuations in intensity of the synchrotron radiation a monitor system was used. A great experimental problem is the strong scattered radiation of short wavelengths which is due to the fact that the continuum of the synchrotron radiation extends into the region of hard X-rays if the accelerator works at energies above 3 GeV (Fig. 1). In the course e rg sec .A.e~ectron 1 10 , FIG. 1. Power radiated as a function of wavelength, after ref. [3]. Article published online by EDP Sciences and available at http://dx.doi.org/10.1051/jphyscol:1971460 GI-332 K. FESER, J. MULLER, G. WIECH AND A. FAESSLER of the experiments the synchrotron was frequently operated at energies up to 7.5 GeV. As can be extrapolated from the curves in figure 1 the power radiated at 7.5 GeV has a maximum at about 0.2 A and an intensity at this wavelength which is by a factor of lo4 higher than at 40 A. The very intense background due to the scattered radiation could be reduced to less than 100 counts/ rnin if the synchrotron is operated at 6 to 7.5 GeV and about 10 mA by careful shielding of the sample and the detector, and by an electronic gate opening the monitor and counting channel only during the acceleration time necessary to give the electrons an energy of 4.5 GeV. Results and discussion. The results of preliminary measurements of the K-emission band of carbon (graphite), boron, and beryllium are shown in figures 24. The position of the detector was changed automati-
Mesenchymal Stem Cell Sheet Encapsulated Cartilage Debris Provides Great Potential for Cartilage Defects Repair in Osteoarthritis

Yiying Qi,Weiqi Yan

DOI: https://doi.org/10.1016/j.mehy.2012.05.024

IF: 4.7

2012-01-01

Medical Hypotheses

Abstract:The restoration of the degenerated articular cartilage in patients with osteoarthritis (OA) is still a challenge for researchers and clinicians. Drug interventions and surgical treatments have been widely attempted for cartilage regeneration in OA. However, the results were largely unsatisfactory. Autologous chondrocyte implantation (ACI) or matrix-induced autologous chondrocyte implantation (MACI) offers potential for the regeneration of cartilage over the long-term. However, due to the limitations and disadvantages of ACI, alternative therapies for cartilage regeneration are in need. The availability of large quantities of mesenchymal stem cells (MSCs) and the multilineage differentiation, especially their chondrogenic differentiation property, have made MSCs the most promising cell source for cartilage regeneration. In addition, MSCs have been shown the ability to undergo site-specific differentiation. MSCs can be obtained as MSC sheets using the temperature-responsive culture dish method. The MSC sheet can provide amounts of cells and extracellular matrix, which might provide the continuity between the implant and host cartilage, thus improving integrative cartilage repair. Moreover, OA is associated with progressive and often severe inflammation. MSCs not only have the ability to contribute structurally to tissue repair, but also possess potent immunomodulatory and anti-inflammatory effects. Taken together, these properties make MSC sheet promising candidate for cartilage repair in OA. We hypothesize that MSC sheet encapsulated cartilage debris can efficiently promote cartilage repair in OA patients. Chondrocytes can be obtained and cultured from small cartilage debris in vitro. Therefore, the chondrocytes may grow from the debris in cartilage defect and improve cartilage regeneration. MSC sheet provide amounts of cells, ECM and protein for cartilage regeneration and integration, and may play some roles of periosteum. The operation of MSC sheet encapsulated cartilage debris for cartilage repair is simple and practical. Moreover, the cell sheet/cartilage debris constructs can be easily shaped based on the size and shape of cartilage defects. The new method might have great potential in treating cartilage defects clinically, especially for OA patients.
Genetically Modified Mesenchymal Stromal Cells in Cartilage Regeneration

Yujun Sun,Chunyu Xue,Haoyu Wu,Changchuan Li,Shixun Li,Jiankai Luo,Taihe Liu,Yue Ding

DOI: https://doi.org/10.1089/scd.2022.0242

Abstract:Articular cartilage injury is common in various conditions, including osteoarthritis, rheumatic diseases, and trauma. Current treatments for cartilage injury fail to completely regenerate the damaged cartilage. Mesenchymal stromal cells (MSCs) have emerged as potential candidates for cartilage regeneration. However, MSCs exhibit hypertrophic differentiation, and their chondrogenic ability is reduced in an inflammatory environment. In recent years, genetic modification has been proposed for optimizing MSC-based therapies, some of which are expected to enter clinical trials. This review summarizes recent research findings and developments in genetic engineering strategies to enhance stem cell-based therapy for cartilage regeneration. We also discuss the mechanisms of biofunctions of MSCs in cartilage regeneration and outline the efficacy and safety of the different genetic modification strategies, including viral and nonviral delivery transduction. Finally, we highlight the major challenges and prospects for clinical translation of genetically modified MSCs.
Mesenchymal stem cell-based therapy for cartilage repair: a review

Hideyuki Koga,Lars Engebretsen,Jan E. Brinchmann,Takeshi Muneta,Ichiro Sekiya

DOI: https://doi.org/10.1007/s00167-009-0782-4

2009-03-31

Abstract:Articular cartilage injury remains one of the major concerns in orthopaedic surgery. Mesenchymal stem cell (MSC) transplantation has been introduced to avoid some of the side effects and complications of current techniques. The purpose of this paper is to review the literature on MSC-based cell therapy for articular cartilage repair to determine if it can be an alternative treatment for cartilage injury. MSCs retain both high proliferative potential and multipotentiality, including chondrogenic differentiation potential, and a number of successful results in transplantation of MSCs into cartilage defects have been reported in animal studies. However, the use of MSCs for cartilage repair is still at the stage of preclinical and phase I studies, and no comparative clinical studies have been reported. Therefore, it is difficult to make conclusions in human studies. This requires randomized clinical trials to evaluate the effectiveness of MSC-based cell therapy for cartilage repair.

surgery,orthopedics,sport sciences
Repair of injured articular and growth plate cartilage using mesenchymal stem cells and chondrogenic gene therapy

Cory J Xian,Bruce K Foster

DOI: https://doi.org/10.2174/157488806776956904

Abstract:Injuries to the articular cartilage and growth plate are significant clinical problems due to their limited ability to regenerate themselves. Despite progress in orthopedic surgery and some success in development of chondrocyte transplantation treatment and in early tissue-engineering work, cartilage regeneration using a biological approach still remains a great challenge. In the last 15 years, researchers have made significant advances and tremendous progress in exploring the potentials of mesenchymal stem cells (MSCs) in cartilage repair. These include (a) identifying readily available sources of and devising appropriate techniques for isolation and culture expansion of MSCs that have good chondrogenic differentiation capability, (b) discovering appropriate growth factors (such as TGF-beta, IGF-I, BMPs, and FGF-2) that promote MSC chondrogenic differentiation, (c) identifying or engineering biological or artificial matrix scaffolds as carriers for MSCs and growth factors for their transplantation and defect filling. In addition, representing another new perspective for cartilage repair is the successful demonstration of gene therapy with chondrogenic growth factors or inflammatory inhibitors (either individually or in combination), either directly to the cartilage tissue or mediated through transducing and transplanting cultured chondrocytes, MSCs or other mesenchymal cells. However, despite these rapid pre-clinical advances and some success in engineering cartilage-like tissue and in repairing articular and growth plate cartilage, challenges of their clinical translation remain. To achieve clinical effectiveness, safety, and practicality of using MSCs for cartilage repair, one critical investigation will be to examine the optimal combination of MSC sources, growth factor cocktails, and supporting carrier matrixes. As more insights are acquired into the critical factors regulating MSC migration, proliferation and chondrogenic differentiation both ex vivo and in vivo, it will be possible clinically to orchestrate desirable repair of injured articular and growth plate cartilage, either by transplanting ex vivo expanded MSCs or MSCs with genetic modifications, or by mobilising endogenous MSCs from adjacent source tissues such as synovium, bone marrow, or trabecular bone.
The Impact on Domestic Productivity of Inward Investment in the UK

N. Driffield

DOI: https://doi.org/10.1111/1467-9957.00237

Abstract:One of the basic tenets of UK industrial policy, that attracting inward investment into the UK stimulates domestic productivity growth, is examined. A model of productivity growth is developed for the indigenous sector of UK manufacturing, linking domestic productivity growth to theoretical explanations of inward investment. The paper demonstrates that inward investment does stimulate productivity growth in the domestic sector of around 0.75 per cent per annum. However, this cannot be attributed to investment or output spillovers, but is a result of the productivity advantage exhibited by the foreign firms.
Allogeneic Primary Mesenchymal Stem/stromal Cell Aggregates Within Poly(n-Isopropylacrylamide-co-acrylic Acid) Hydrogel for Osteochondral Regeneration

Jiabin Zhang,Ming Zhang,Rongcai Lin,Seonho Yun,Yuguang Du,Liming Wang,Qingqiang Yao,Andrew Zannettino,Hu Zhang

DOI: https://doi.org/10.1016/j.apmt.2019.100487

IF: 8.663

2019-01-01

Applied Materials Today

Abstract:Osteoarthritis (OA) is an inflammation-related chronic disease that causes progressive degeneration of cartilage, which might even extend to subchondral bones. Due to the unique physiological structural differences between cartilage and subchondral bone, it is challenging to restore the full function of an osteochondral defect. In this study, a thermosensitive poly(N-isopropylacrylamide-co-acrylic acid) (p(NIPAAm-AA)) hydrogel was used as a carrier for allogeneic primary mesenchymal stem/stromal cells to determine the therapeutic efficacy of the cell-hydrogel hybrid on osteochondral regeneration. At a similar mechanical strength, p(NIPAAm-AA) hydrogel facilitates formation of cell aggregates of allogeneic primary MSCs in situ, while the fibrin hydrogel supports cell binding and the development of a spindle morphology. While the p(NIPAAm-AA) hydrogel did not induce any inflammatory effects, the fibrin hydrogel was found to elicit a pro-inflammatory response. MSC aggregates promotes expression of paracrine signaling-related genes (TGFB1, VEGF, CXCL12, IGF1, BMP2, BMP7, WNT3A, CTNNB1) as well as expression of chondrogenesis-related genes (SOX9, ACAN, and COL2A1) and generation of extracellular matrices (ECMs) (type 2 collagen and glycosaminoglycans) in chondrogenic induction medium. The functional enhancement of paracrine effects by MSC aggregates (i.e. the immunomodulatory effect and the stimulation of stem/progenitor cells homing) and induced differentiation of MSCs might play a synergistic role in the generation of the neo-cartilage and subchondral bone at an osteochondral defect site in vivo. Delivery of primary allogeneic MSCs in the context of a thermosensitive p(NIPAAm-AA) hydrogel to an osteochondral defect site may be a novel and promising strategy for osteochondral regeneration.
Mechanical stimulation of mesenchymal stem cells: Implications for cartilage tissue engineering

Niamh Fahy,Mauro Alini,Martin J. Stoddart

DOI: https://doi.org/10.1002/jor.23670

2017-08-11

Journal of Orthopaedic Research

Abstract:Articular cartilage is a load-bearing tissue playing a crucial mechanical role in diarthrodial joints, facilitating joint articulation, and minimizing wear. The significance of biomechanical stimuli in the development of cartilage and maintenance of chondrocyte phenotype in adult tissues has been well documented. Furthermore, dysregulated loading is associated with cartilage pathology highlighting the importance of mechanical cues in cartilage homeostasis. The repair of damaged articular cartilage resulting from trauma or degenerative joint disease poses a major challenge due to a low intrinsic capacity of cartilage for self-renewal, attributable to its avascular nature. Bone marrow-derived mesenchymal stem cells (MSCs) are considered a promising cell type for cartilage replacement strategies due to their chondrogenic differentiation potential. Chondrogenesis of MSCs is influenced not only by biological factors but also by the environment itself, and various efforts to date have focused on harnessing biomechanics to enhance chondrogenic differentiation of MSCs. Furthermore, recapitulating mechanical cues associated with cartilage development and homeostasis in vivo, may facilitate the development of a cellular phenotype resembling native articular cartilage. The goal of this review is to summarize current literature examining the effect of mechanical cues on cartilage homeostasis, disease, and MSC chondrogenesis. The role of biological factors produced by MSCs in response to mechanical loading will also be examined. An in-depth understanding of the impact of mechanical stimulation on the chondrogenic differentiation of MSCs in terms of endogenous bioactive factor production and signaling pathways involved, may identify therapeutic targets and facilitate the development of more robust strategies for cartilage replacement using MSCs. © 2017 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 36:52-63, 2018.
Treatment and application of stem cells from different sources for cartilage injury: a literature review

Pengzhen Wang,Shaoheng Zhang,Qingqi Meng,Pingping Zhu,Wei Yuan

DOI: https://doi.org/10.21037/atm-22-1715

IF: 3.616

2022-05-20

Annals of Translational Medicine

Abstract:Background and Objective: Cartilage defects and degeneration have a major impact on daily mobility and quality of life for millions of people worldwide. As the most effective seed cells for tissue engineering applications in regenerative medicine, mesenchymal stem cells (MSCs) are pluripotent cells with mesoderm and neural crest origin. The combination of biomaterial scaffolds with stem cells and drugs for cartilage damage repair has brought much hope to the medical field.Methods: We searched and compared the literature on cartilage damage repaired by stem cells through PubMed and Web of Science method, this review summarizes the research progress of mesenchymal stem cells from various tissue sources in repairing articular cartilage injury.Key Content and Findings: We found that peripheral blood, bone marrow, umbilical cord blood, adipose tissue, and umbilical cord are classic stem cell sources. Stem cells can be stimulated by various growth factors, recombinant proteins, or important monomers to generate cartilage in vitro. At the same time, MSCs obtained from various sources can secrete different growth factors to further regulate their own cartilage formation. These stem cells may promote the cartilage damage repair by promoting differentiation and fighting inflammation.Conclusions: This review summarizes and discusses the advantages and disadvantages of the ability of MSCs from different sources to treat cartilage injury, and provides help and identification for the subsequent in-depth research and preclinical application of various MSCs.

oncology,medicine, research & experimental
Mesenchymal stromal cell-based therapy for cartilage regeneration in knee osteoarthritis

Xiao-Na Xiang,Si-Yi Zhu,Hong-Chen He,Xi Yu,Yang Xu,Cheng-Qi He

DOI: https://doi.org/10.1186/s13287-021-02689-9

2022-01-10

Abstract:Abstract Osteoarthritis, as a degenerative disease, is a common problem and results in high socioeconomic costs and rates of disability. The most commonly affected joint is the knee and characterized by progressive destruction of articular cartilage, loss of extracellular matrix, and progressive inflammation. Mesenchymal stromal cell (MSC)-based therapy has been explored as a new regenerative treatment for knee osteoarthritis in recent years. However, the detailed functions of MSC-based therapy and related mechanism, especially of cartilage regeneration, have not been explained. Hence, this review summarized how to choose, authenticate, and culture different origins of MSCs and derived exosomes. Moreover, clinical application and the latest mechanistical findings of MSC-based therapy in cartilage regeneration were also demonstrated.

cell biology,medicine, research & experimental,cell & tissue engineering
Pediatric case of the day. Small bowel (ileal) volvulus and ileal atresia.

C. G. Zaleski,G. Abdenour,M. B. Mata

DOI: https://doi.org/10.1148/RADIOGRAPHICS.17.2.9084090

1997-03-01

Radiographics

Abstract:
Mesenchymal stem cells in orthopaedics: A systematic review of applications to practice

Ajith Malige,Carson Gates,James L Cook

DOI: https://doi.org/10.1016/j.jor.2024.06.026

2024-06-22

Abstract:Background: Mesenchymal stem cells (MSCs) have alluring interest for clinical use in orthopaedics based on their therapeutic potential through directed pluripotent differentiation. While many studies and reviews have discussed the importance of this approach, few have reduced it to practice using reproducible criteria. This study was designed to systematically review and synthesize current evidence regarding clinical use of clearly defined MSCs in orthopaedics. Methods: Studies of any level of evidence and sample size, regardless of MSC source, orthopaedic pathology, and patient population, were reviewed. In vitro and animal studies, and articles written in a language other than English, were excluded. Studies were then screened for final inclusion based on documented MSC verification using testing of the therapeutic cellular population for at least one of the following phenotypic markers: CD 73, CD 90, and CD 105. In addition, therapeutic cellular populations could not have higher percentages of CD34, CD45, CD14, HLA-DR, CD11b, or CD19 markers compared to the aforementioned markers. From each studies' results, sample size, procedural methods, radiographic outcomes, clinical outcomes, patient-report outcomes (PROs), and adverse events were tabulated. Results: Overall, 43 studies were included. Twenty-three studies (53.5 %) derived their MSCs from iliac crest bone marrow while 12 (27.9 %) studied adipose-derived MSCs. Included studies explored MSC use in Osteoarthritis, Cartilage Defects, Osteonecrosis, Bone Defects and Nonunions, Spine, and Other. MSC use in all pathologies led to improvement of studied radiographic, clinical, and patient-reported outcomes. Conclusions: Mesenchymal stem cells have proven to have successful and safe uses in multiple orthopaedic applications, including treating chondral defects, osteoarthritis, and osteonecrosis. A stringent and reproducible process for evaluating obtained human stem cells using CD markers for clinical use is necessary to both evaluate previous studies and continue to evaluate for future uses. Level of evidence: Level V.
Mesenchymal stem cell-based therapy of osteoarthritis: Current knowledge and future perspectives

C Randall Harrell,Bojana Simovic Markovic,Crissy Fellabaum,Aleksandar Arsenijevic,Vladislav Volarevic

DOI: https://doi.org/10.1016/j.biopha.2018.11.099

Abstract:Osteoarthritis (OA) is a chronic, prevalent, debilitating joint disease characterized by progressive cartilage degradation, subchondral bone remodeling, bone marrow lesions, meniscal damage, and synovitis. Innate immune cells (natural killer cells, macrophages, and mast cells) play the most important pathogenic role in the early inflammatory response, while cells of adaptive immunity (CD4 + Th1 lymphocytes and antibody producing B cells) significantly contribute to the development of chronic, relapsing course of inflammation in OA patients. Conventional therapy for OA is directed toward symptomatic treatment, mainly pain management, and is not able to promote regeneration of degenerated cartilage or to attenuate joint inflammation. Since articular cartilage, intra-articular ligaments, and menisci have no ability to heal, regeneration of these tissues remains one of the most important goals of new therapeutic approaches used for OA treatment. Due to their capacity for differentiation into chondrocytes and due to their immunomodulatory properties, mesenchymal stem cells (MSCs) have been the most extensively explored as new therapeutic agents in the cell-based therapy of OA. Simple acquisition, rapid proliferation, maintenance of differentiation potential after repeated passages in vitro, minor immunological rejection due to the low surface expression of major histocompatibility complex antigens, efficient engraftment and long-term coexistence in the host are the main characteristics of MSCs that enable their therapeutic use in OA. In this review article, we emphasized current knowledge and future perspectives regarding molecular and cellular mechanisms responsible for beneficial effects of autologous and allogeneic MSCs in the treatment of OA.
Use of mesenchymal stem cells seeded on the scaffold in articular cartilage repair

Kaoru Yamagata,Shingo Nakayamada,Yoshiya Tanaka

DOI: https://doi.org/10.1186/s41232-018-0061-1

2018-03-12

Inflammation and Regeneration

Abstract:Articular cartilage has poor capacity for repair. Once damaged, they degenerate, causing functional impairment of joints. Allogeneic cartilage transplantation has been performed for functional recovery of articular cartilage. However, there is only a limited amount of articular cartilage available for transplantation. Mesenchymal stem cells (MSCs) could be potentially suitable for local implantation. MSCs can differentiate into chondrocytes. Several studies have demonstrated the therapeutic potential of MSCs in the repair of articular cartilage in animal models of articular cartilage damage and in patients with damaged articular cartilage. To boost post-implantation MSC differentiation into chondrocytes, the alternative delivery methods by scaffolds, using hyaluronic acid (HA) or poly-lactic-co-glycolic-acid (PLGA), have developed. In this review, we report recent data on the repair of articular cartilage and discuss future developments.

immunology,medicine, research & experimental
Heterogeneity of mesenchymal stem cells in cartilage regeneration: from characterization to application

Kangkang Zha,Xu Li,Zhen Yang,Guangzhao Tian,Zhiqiang Sun,Xiang Sui,Yongjing Dai,Shuyun Liu,Quanyi Guo

DOI: https://doi.org/10.1038/s41536-021-00122-6

IF: 14.404

2021-03-19

npj Regenerative Medicine

Abstract:Abstract Articular cartilage is susceptible to damage but hard to self-repair due to its avascular nature. Traditional treatment methods are not able to produce satisfactory effects. Mesenchymal stem cells (MSCs) have shown great promise in cartilage repair. However, the therapeutic effect of MSCs is often unstable partly due to their heterogeneity. Understanding the heterogeneity of MSCs and the potential of different types of MSCs for cartilage regeneration will facilitate the selection of superior MSCs for treating cartilage damage. This review provides an overview of the heterogeneity of MSCs at the donor, tissue source and cell immunophenotype levels, including their cytological properties, such as their ability for proliferation, chondrogenic differentiation and immunoregulation, as well as their current applications in cartilage regeneration. This information will improve the precision of MSC-based therapeutic strategies, thus maximizing the efficiency of articular cartilage repair.

cell & tissue engineering,engineering, biomedical
Advances in cartilage tissue regeneration: a review of stem cell therapies, tissue engineering, biomaterials, and clinical trials

Julia Skoracka,Kaja Bajewska,Maciej Kulawik,Wiktoria Suchorska,Katarzyna Kulcenty

DOI: https://doi.org/10.17179/excli2024-7088

2024-09-03

Abstract:Cartilage tissue, characterized by its limited regenerative capacity, presents significant challenges in clinical therapy. Recent advancements in cartilage regeneration have focused on integrating stem cell therapies, tissue engineering strategies, and advanced modeling techniques to overcome existing limitations. Stem cells, particularly Mesenchymal Stem Cells (MSCs) and induced pluripotent stem cells (iPSCs), hold promise for cartilage repair due to their ability to differentiate into chondrocytes, the key cells responsible for cartilage formation. Tissue engineering approaches, including 3D models, organ-on-a-chip systems, and organoids, offer innovative methods to mimic natural tissue microenvironments and evaluate potential treatments. MSC-based techniques, such as cell sheet tissue engineering, address challenges associated with traditional therapies, including cell availability and culture difficulties. Furthermore, advancements in 3D bioprinting enable the fabrication of complex tissue structures, while organ-on-a-chip systems provide microfluidic platforms for disease modeling and physiological mimicry. Organoids serve as simplified models of organs, capturing some complexity and enabling the monitoring of pathophysiological aspects of cartilage diseases. This comprehensive review underscores the transformative potential of integrating stem cell therapies, tissue engineering strategies, and advanced modeling techniques to improve cartilage regeneration and pave the way for more effective clinical treatments.
Blunt Injury of the Pancreas

A. Cameron,J. Wellwood

DOI: https://doi.org/10.1111/j.1742-1241.1983.tb08459.x

1983-01-01

Abstract:CASE REPORT The patient, a 22-year old female, presented to the Accident Department 8 hours after being kicked in the abdomen. She had felt no pain at the time, but was awakened from sleep by severe epigastric pain radiating to the right iliac fossa . On examination she was not shocked, but there was upper abdominal guarding and tenderness. Abdominal X-rays were normal, haemoglobin was 14.6g/dL, but white cell count was 18.8 x 10/L and serum am ylase was 760 1U/L (NR < 290). Laparotomy was performed ; there was no free blood or fluid in the peritoneal cavity , and the intraperitoneal viscera were undamaged . The anterior sur face of the pancreas was bruised, but no other abnormality was noted, and the abdomen was closed without drainage. The patient made an uncomplicated recovery, and was discharged home after 8 days. Six weeks later she presented again in the Accident Department with a 12-hour history of epigastric pain, radiating again to the right iliac fossa but not to the back . On examination there was only slight epigastric tenderness, but the serum am ylase was 5050 IU/L. Th is pancreatitis was managed conservat ively with intravenous fluids, nasogastric suction and antibiotics, and the patient made a speedy recovery. Ho wever , although she was asymptomatic, the serum amylase remained persistently elevated (c. 3000 1U/L) . At no time was an epiga stric mass palpable, and a hypotonic duodenogram was normal. Figure 1. Long itu dinal midlin e abdo minal ult rasoun d scan. AAW: anteri or abdom inal w all L: live r AO : aorta wi th supe rior mesente ric artery out lined C: pancreat ic cyst .
Harnessing knee joint resident mesenchymal stem cells in cartilage tissue engineering

Xiao Xu,Limei Xu,Jiang Xia,Caining Wen,Yujie Liang,Yuanmin Zhang

DOI: https://doi.org/10.1016/j.actbio.2023.07.024

2023-09-15

Abstract:Osteoarthritis (OA) is a widespread clinical disease characterized by cartilage degeneration in middle-aged and elderly people. Currently, there is no effective treatment for OA apart from total joint replacement in advanced stages. Mesenchymal stem cells (MSCs) are a type of adult stem cell with diverse differentiation capabilities and immunomodulatory potentials. MSCs are known to effectively regulate the cartilage microenvironment, promote cartilage regeneration, and alleviate OA symptoms. As a result, they are promising sources of cells for OA therapy. Recent studies have revealed the presence of resident MSCs in synovial fluid, synovial membrane, and articular cartilage, which can be collected as knee joint-derived MSCs (KJD-MSC). Several preclinical and clinical studies have demonstrated that KJD-MSCs have great potential for OA treatment, whether applied alone, in combination with biomaterials, or as exocrine MSCs. In this article, we will review the characteristics of MSCs in the joints, including their cytological characteristics, such as proliferation, cartilage differentiation, and immunomodulatory abilities, as well as the biological function of MSC exosomes. We will also discuss the use of tissue engineering in OA treatment and introduce the concept of a new generation of stem cell-based tissue engineering therapy, including the use of engineering, gene therapy, and gene editing techniques to create KJD-MSCs or KJD-MSC derivative exosomes with improved functionality and targeted delivery. These advances aim to maximize the efficiency of cartilage tissue engineering and provide new strategies to overcome the bottleneck of OA therapy. STATEMENT OF SIGNIFICANCE: This research will provide new insights into the medicinal benefit of Joint resident Mesenchymal Stem Cells (MSCs), specifically on its cartilage tissue engineering ability. Through this review, the community will further realize promoting joint resident mesenchymal stem cells, especially cartilage progenitor/MSC-like progenitor cells (CPSC), as a preventive measure against osteoarthritis and cartilage injury. People and medical institutions may also consider cartilage derived MSC as an alternative approach against cartilage degeneration. Moreover, the discussion presented in this study will convey valuable information for future research that will explore the medicinal benefits of cartilage derived MSC.
Peripheral Blood-Derived Stem Cells for the Treatment of Cartilage Injuries: A Systematic Review

Yanlin Zhu,Weili Fu

DOI: https://doi.org/10.3389/fbioe.2022.956614

IF: 5.7

2022-07-22

Frontiers in Bioengineering and Biotechnology

Abstract:Background: The treatment of cartilage damage is a hot topic at present, and cell therapy is an emerging alternative therapy. Stem cells derived from peripheral blood have become the focus of current research due to the ease of obtaining materials and a wide range of sources. Methods: We used a text search strategy using the ["mesenchymal stem cells" (MeSH term) OR "MSC" OR "BMMSC" OR "PBMSC" OR" PBMNC" OR "peripheral blood stem cells"] AND (cartilage injury [MeSH term] OR "cartilage" OR "chondral lesion"). After searching the literature, through the inclusion and exclusion criteria, the last included articles were systematically reviewed. Result: We found that peripheral blood-derived stem cells have chondrogenic differentiation ability and can induce chondrogenic differentiation and repair in vivo and have statistical significance in clinical and imaging prognosis. It is an improvement of academic differences. Compared with the bone marrow, peripheral blood is easier to obtain, widely sourced, and simple to obtain. In the future, peripheral blood will be a more potential cell source for cell therapy in the treatment of cartilage damage. Conclusion: Stem cells derived from peripheral blood can repair cartilage and are an important resource for the treatment of cartilage damage in the future. The specific mechanism and way of repairing cartilage need further study.

multidisciplinary sciences

Beiträge zur Kenntniss der Antitoxinbildung

Mesenchymal stem cell-based treatment for cartilage defects in osteoarthritis

FLUORESCENCE EXCITATION OF ULTRA-SOFT X-RAY EMISSION SPECTRA USING SYNCHROTRON RADIATION.

Mesenchymal Stem Cell Sheet Encapsulated Cartilage Debris Provides Great Potential for Cartilage Defects Repair in Osteoarthritis

Genetically Modified Mesenchymal Stromal Cells in Cartilage Regeneration

Mesenchymal stem cell-based therapy for cartilage repair: a review

Repair of injured articular and growth plate cartilage using mesenchymal stem cells and chondrogenic gene therapy

The Impact on Domestic Productivity of Inward Investment in the UK

Allogeneic Primary Mesenchymal Stem/stromal Cell Aggregates Within Poly(n-Isopropylacrylamide-co-acrylic Acid) Hydrogel for Osteochondral Regeneration

Mechanical stimulation of mesenchymal stem cells: Implications for cartilage tissue engineering

Treatment and application of stem cells from different sources for cartilage injury: a literature review

Mesenchymal stromal cell-based therapy for cartilage regeneration in knee osteoarthritis

Pediatric case of the day. Small bowel (ileal) volvulus and ileal atresia.

Mesenchymal stem cells in orthopaedics: A systematic review of applications to practice

Mesenchymal stem cell-based therapy of osteoarthritis: Current knowledge and future perspectives

Use of mesenchymal stem cells seeded on the scaffold in articular cartilage repair

Heterogeneity of mesenchymal stem cells in cartilage regeneration: from characterization to application

Advances in cartilage tissue regeneration: a review of stem cell therapies, tissue engineering, biomaterials, and clinical trials

Blunt Injury of the Pancreas

Harnessing knee joint resident mesenchymal stem cells in cartilage tissue engineering

Peripheral Blood-Derived Stem Cells for the Treatment of Cartilage Injuries: A Systematic Review